Profile
Peter Verwaijen is currently the Global Head-Brand Strategy & Commercial Business at Egetis Therapeutics AB since 2024.
Formerly, Mr. Verwaijen was Controller at Glaucus Proteomics BV and Vice President-Finance at AM-Pharma BV.
Peter Verwaijen active positions
| Companies | Position | Start |
|---|---|---|
| EGETIS THERAPEUTICS AB | Corporate Officer/Principal | 2024-09-30 |
Former positions of Peter Verwaijen
| Companies | Position | End |
|---|---|---|
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Director of Finance/CFO | - |
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Develops antibody and protein array technologies to optimize drug development and disease management | Comptroller/Controller/Auditor | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Develops antibody and protein array technologies to optimize drug development and disease management | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Peter Verwaijen
















